drugset / Trial / NCT00603044
Mechanism of Action of Fluticasone Furoate in Childhood Obstructive Sleep Apnea Syndrome
RandomizedParallel-groupOpen-labelBasic science
Summary
The purpose of this research is to find out how a nasal spray (fluticasone furoate), sometimes given to children with obstructive sleep apnea syndrome (OSAS), works on certain cells within a child's adenoids. We hypothesize that intranasal steroids lead to an upregulation of T regulatory cells in the adenoid tissues of children with OSAS. This will result in a local reduction in inflammation and edema explaining the improvement in OSAS.
Timeline
- Start
- 2008-01
- Primary completion
- 2009-01
- Completion
- 2009-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Fluticasone Furoate | Other / unclassified | 55 ug | Intranasal |